Taken together, we identified a new mechanism of IL-18-mediated activation of MAIT cells, which added a new layer of hyperactivation of MAIT cells in patients with PBC and suggested that IL-18 and IL-18R might be a therapeutic target for PBC. Here, IL18R1 is linked to primary biliary cholangitis.